Compounds > iodoazomycin arabinoside
Page last updated: 2024-09-03

iodoazomycin arabinoside and Cancer of Prostate

iodoazomycin arabinoside has been researched along with Cancer of Prostate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Diaz-Dussan, D; Kumar, P; Macdonald, D; Narain, R; Peng, YY; Rashed, FB; Weinfeld, M1
Chapman, JD; Mannan, RH; McEwan, AJ; McPhee, MS; Mercer, JR; Moore, RB; Wiebe, LI1
Biskupiak, JE; Krohn, KA1

Other Studies

3 other study(ies) available for iodoazomycin arabinoside and Cancer of Prostate

ArticleYear
Optimized Carbohydrate-Based Nanogel Formulation to Sensitize Hypoxic Tumors.
    Molecular pharmaceutics, 2023, 06-05, Volume: 20, Issue:6

    Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Galactose; Humans; Hypoxia; Male; Mice; Nanogels; Prostatic Neoplasms

2023
Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine-123-iodoazomycin arabinoside.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:3

    Topics: Animals; Brain; Cell Hypoxia; Iodine Radioisotopes; Magnetic Resonance Spectroscopy; Male; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Photochemotherapy; Prostatic Neoplasms; Radionuclide Imaging; Rats; Tumor Cells, Cultured

1993
Second generation hypoxia imaging agents.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:3

    Topics: Animals; Cell Hypoxia; Iodine Radioisotopes; Male; Nitroimidazoles; Oxygen; Photochemotherapy; Prostatic Neoplasms; Radionuclide Imaging; Rats

1993